Self-reactive antibodies (natural autoantibodies) in healthy individuals
about
Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humansThe Production Processes and Biological Effects of Intravenous ImmunoglobulinProfiling of alopecia areata autoantigens based on protein microarray technology.Human immunoglobulin A (IgA)-specific ligands from combinatorial engineering of protein A.Evidence that human autoimmune thrombocytopenia mediated by both immunoglobulin isotypes IgM and IgG is an independent disease entity.Exposure to the Epstein-Barr Viral Antigen Latent Membrane Protein 1 Induces Myelin-Reactive Antibodies In VivoAutoantibodies to folate receptor alpha during early pregnancy and risk of oral clefts in DenmarkCord blood CD4+ T cells respond to self heat shock protein 60 (HSP60)Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infectionExquisite specificity and peptide epitope recognition promiscuity, properties shared by antibodies from sharks to humans.The immune tolerance network and rheumatic disease: immune tolerance comes to the clinic.Antigen-Experienced CD4lo T Cells Are Linked to Deficient Contraction of the Immune Response in Autoimmune DiabetesIs Tourette's syndrome an autoimmune disease?Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.The conservative physiology of the immune system.Natural and disease-specific autoantibodies in chronic obstructive pulmonary diseaseIncreased biodiversity in the environment improves the humoral response of rats.Positive selection of natural poly-reactive B cells in the periphery occurs independent of heavy chain allelic inclusionProtective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathwayEliminating antibody polyreactivity through addition of N-linked glycosylation.Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages.Autopolyreactivity Confers a Holistic Role in the Immune System.Igkappa allelic inclusion is a consequence of receptor editing.Antigen-chip technology for accessing global information about the state of the body.Anti-ergotypic immunoregulation.Tic disorders: neural circuits, neurochemistry, and neuroimmunology.General Assessment of Humoral Activity in Healthy Humans.Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire.Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes.The auto-antigen repertoire in myasthenia gravis.Autoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence.Secreted tumor antigens - immune biomarkers for diagnosis and therapy.Self-reactivity in the dimeric intravenous immunoglobulin fraction.Human monoclonal natural autoantibodies against the T-cell receptor inhibit interleukin-2 production in murine T cells.Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis.Intravenous immunoglobulin treatment in chronic neurological diseases: do we have maintenance dose right?Heat treatment of normal human sera reveals antibodies to bactericidal permeability-inducing protein (BPI).Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
P2860
Q24599636-AD7B4942-DCF6-45C5-9A15-6CB35A9DD566Q26752540-2D140106-B9F1-48F7-8CD2-A390CF5C1730Q30785189-8EE8F8AC-CE85-4304-A23F-8453EFD28288Q31067966-48632AF6-C24E-47AA-BD83-BDF0D6782FEFQ33368317-20564E38-96BB-42F8-8F1B-6DE5DD242CB9Q33875219-C39AD8DB-1111-48C8-B719-8B43063A21A9Q34019461-05653F5B-FC02-4861-B868-D213D0DA42E4Q34023284-8FF13667-50C5-4128-87B8-C61FE9EB9E56Q34117580-F9D8C009-C36F-4069-B355-E4281BCCA14FQ34218267-02B376F5-B9A5-491F-9228-EB61CB11F268Q34338802-E46CD079-9775-4426-8FAE-EB006A1F27AFQ34424442-2D3E5105-9ED4-4289-9ED6-2DC20DB1036CQ34705346-B40DE249-1BA7-484D-9DF5-A1868161C84CQ34760606-958375DD-8961-4EB8-9F00-CEFA8838128DQ34835462-B9D0016C-D487-4FB3-BE81-E4C5B5EC6F18Q35047532-664764FA-4E29-4AF5-A083-317B90D6AA48Q35198950-F59A9BF1-199C-4F79-9669-2EE0E9495F9CQ35326232-8B291D2C-EF63-47ED-A867-4C97D6344504Q35636916-D36D7DC2-BCE0-4621-938D-3E3AC0E8F73CQ35676010-F9712FF2-1FED-4417-90C5-44EBAFC5BA85Q35684786-810D14CA-6BE0-41A0-94BA-DA12DA648F41Q35690592-499EC365-C325-426F-B7D6-39D3D1644802Q35903515-49723AC3-66F2-4D73-BA79-253685679CEEQ36228958-480F5603-4C73-41B4-BBD3-2D95380980FAQ36560787-95AAF23D-048A-44ED-A2D8-AEA51214FA2CQ36570660-AF6DA03E-328E-44F6-A2D8-74154E8F1F99Q36592783-A1FDBD08-CA2D-488A-B3C9-BABF4AA16D2DQ36876103-2EAF4DC4-F925-4DDD-9B82-9F8B4458394BQ37019872-979942B0-9AB8-47B0-B83A-5B41F1AF488FQ37540582-E98CE656-BAC7-4E8B-A9C1-CD8E8379724FQ37569949-CF95FC70-88DB-4A0D-933C-983897A6590BQ37727984-712380AF-2A56-4524-9024-7AAC7962705FQ37990551-423A896C-F821-4731-8ED3-275208816E55Q39438407-507C5FD7-B370-495B-9CF9-2DAF360E0B56Q40073137-664DEE91-4ABE-4120-AA73-E9A68C9C3155Q40734975-731D46BF-9CAB-4BB6-806D-A8593A63A507Q42264145-22258282-1EA0-492A-A561-BE4B00115A93Q43087483-65E3D93B-F41A-4A21-8BCD-7AB28F38726DQ43488690-ED1300D4-1EDC-4364-A5AF-5331E2FCAFC4Q43717482-9AA03419-4B77-4650-B34D-5EEFB64D0E38
P2860
Self-reactive antibodies (natural autoantibodies) in healthy individuals
description
scientific article published on 01 July 1998
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 1998
@uk
name
Self-reactive antibodies (natural autoantibodies) in healthy individuals
@en
Self-reactive antibodies
@nl
type
label
Self-reactive antibodies (natural autoantibodies) in healthy individuals
@en
Self-reactive antibodies
@nl
prefLabel
Self-reactive antibodies (natural autoantibodies) in healthy individuals
@en
Self-reactive antibodies
@nl
P2093
P50
P1476
Self-reactive antibodies (natural autoantibodies) in healthy individuals
@en
P2093
E Malanchère
M D Kazatchkine
S V Kaveri
P304
P356
10.1016/S0022-1759(98)00074-X
P577
1998-07-01T00:00:00Z